Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business9 December 2014Corporate and M&ADeal watchUS firms One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryThirty firms win roles in revamped £820m government legal panel – with three new appointmentsRopes London private equity exits continue with partner duo set for AkinRevolving Doors: Bumper hiring week at Eversheds while Quinn brings on international arbitration heavyweight‘For us, it all came together’ – how Proskauer built a London high yield offering in 12 monthsSlaughters, Gibson Dunn lead on Daily Mail’s £500m Telegraph Media Group acquisitionCohen & Gresser follows McDermott in eyeing up external investment‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLegal 500 US: Latham tops the charts in new US rankingsDealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega deal